Large-Scale Smartwatch Intervention Trial Targets Cardiovascular Risk in Pre-Disease States — 1,400 Participant Study
247 Health News Editorial
·7 Apr 2026
·4 min read
·clinical-trialsA large-scale Chinese trial is testing whether smartwatch-based interventions can prevent cardiovascular disease in 1,400 overweight individuals with pre-disease conditions. The study targets the critical window before hypertension, diabetes, and dyslipidemia develop.
Originally reported by ClinicalTrials.gov
References
- 1.Beijing Anzhen Hospital. (2024). A Smart Wearable Devices-based Comprehensive Intervention Through a Cluster Randomized Controlled Trial to Improve Cardiovascular Health in Overweight/Obese Individuals With Cardiometabolic Preconditions. ClinicalTrials.gov. NCT07372729. https://clinicaltrials.gov/study/NCT07372729
- 2.Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., Sharma, G., & Rosamond, W. (2022). Life's Essential 8: Updating and Enhancing the American Heart Association's Construct for Cardiovascular Health. Circulation, 146(5), e18-e43. https://doi.org/10.1161/CIR.0000000000001078
- 3.Cadmus-Bertram, L. A., Marcus, B. H., Patterson, R. E., Parker, B. A., & Morey, B. L. (2015). Randomized trial of a Fitbit-based physical activity intervention for women. American Journal of Preventive Medicine, 49(3), 414-418. https://doi.org/10.1016/j.amepre.2015.01.020
- 4.Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., Bonny, A., Brauer, M., Brodmann, M., Cahill, T. J., Carapetis, J., Catapano, A. L., Chugh, S. S., Cooper, L. T., Coresh, J., ... Fuster, V. (2020). Global burden of cardiovascular diseases and risk factors, 1990-2019. Journal of the American College of Cardiology, 76(25), 2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010
- 5.Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I. M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., Nonas, C. A., Sacks, F. M., Smith, S. C., Svetkey, L. P., Wadden, T. A., & Yanovski, S. Z. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation, 129(25 Suppl 2), S76-S99. https://doi.org/10.1161/01.cir.0000437740.48606.d1
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service